Home General Biotechnology Drug Patent Expirations in December 2009

Drug Patent Expirations in December 2009

Drug Patent Expirations for December 2009

TradenameApplicantGeneric NamePatent Number Patent Expiration
MIGRANALValeantdihydroergotamine mesylate5,169,849Dec 8, 2009
PHOTOFRINAxcan Scandipharmporfimer sodium5,145,863Dec 15, 2009
XENICALHoffmann La Rocheorlistat4,598,089*PEDDec 18, 2009
CEDAXSciele Pharma Incceftibuten dihydrate4,812,561Dec 20, 2009
OXILAN-300Guerbetioxilan4,954,348Dec 21, 2009
OXILAN-350Guerbetioxilan4,954,348Dec 21, 2009
DEFINITYLantheus Medclperflutren6,146,657Dec 22, 2009
ZANTAC 150Glaxosmithklineranitidine hydrochloride5,102,665*PEDDec 23, 2009
VALTREXGlaxosmithklinevalacyclovir hydrochloride4,957,924*PEDDec 23, 2009
ZIAGENGlaxosmithklineabacavir sulfate5,089,500*PEDDec 26, 2009
TRIZIVIRGlaxosmithklineabacavir sulfate; lamivudine; zidovudine5,089,500*PEDDec 26, 2009
EPZICOMSmithkline Beechamabacavir sulfate; lamivudine5,089,500*PEDDec 26, 2009
CORVERTPharmacia And Upjohnibutilide fumarate5,155,268Dec 28, 2009

*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Courtesy of DrugPatentWatch.com

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

NO COMMENTS

Leave a Reply